Brain Cancer

A recent study showed that socioeconomic status may explain racial and ethnic disparities found among childhood cancer survivors of certain cancers.

When John McCain died this week, I was reminded of another patient who died of this nasty disease.

Senator and former presidential candidate John McCain died of glioblastoma on Aug. 25. He was 81 years old.

The senator's family announced that he will no longer be undergoing treatment for glioblastoma.

In recent years, immunotherapy has been falling flat in the brain cancer field, but recent research may change that.

The potential differences in the genetic risk factors among men and women for developing glioma may shed light on a new way to assess such risks, according to a meta-analysis published in Scientific Reports.

An Idaho teenager a boost from one of her idols — former Vice President Joe Biden — during her treatment for acute myeloid leukemia.

Research continues to drive the oncology field.

I was given a three- to five-year life expectancy. I told my neuro-oncologist at Memorial Sloan Kettering Cancer Center that all I heard was that I could expect more life.

The approach used in discussing palliative care can play a role in whether a patient seeks help.

Innovations in drug development, surgery, radiation and clinical trials have investigators hard at work in glioblastoma.

My heart seeks joy. My life is joyful, full of light. And I know trauma can live in the light, I have seen it and lived it.

Researchers from Duke Cancer Institute in Durham, North Carolina, developed a genetically modified poliovirus to attack the rare but aggressive brain cancer by directly injecting the virus into the tumor.

The majority of adolescent and young adult (AYA) patients who are diagnosed with cancer are expected to live past the five-year mark, though survival and health outcomes seem to differ by disease type, according to recent research published in the journal Cancer.

When my mom got cancer, the last thing on my mind was my own health, but she had the foresight and the care to get a genetic test so that her kids could live long and healthy lives. Today I am grateful for my mom, my whole family and the magic of science.

Researchers identified six gene variations that play an important role in the treatment and surveillance of children with medulloblastoma, for which they developed screening and counseling recommendations.

The ways life hits us with various challenges is neither fair nor fun, but we can still find happiness.

Chronic illness causes a lot of pain, and pain always carries fear with it. One way to cope is to recognize that fear can co-exist with many other feelings. It is OK to be scared, and it is OK to keep going.

Explore why I'm still here as a 20-year brain tumor survivor, and watch a video about my story with insights to thrive.

Although still in early phases, an oncolytic virus, called DNX-2401, may be a groundbreaking therapy in pediatric patients with diffuse intrinsic pontine gliomas.

The photographers’ excitement to be involved led to a number of photo sessions for “fighter families” as Dawson calls them. After just a few sessions, it was apparent the Gold Hope Project was a hit.

For those of us living with (and taking care of) people living with brain tumors, cancers and other diseases that become chronic, life's challenges begin to shift, as do our outlooks. It is important for us to be able to love our bodies, our disabilities, and for the world to make space for all sorts of bodies to exist.

Berubicin showed promise in the treatment of glioblastoma as a drug that was able to cross the blood-brain barrier.

When stuck in this space, it is tempting to hide from life, but with all the beauty in the world, it doesn't serve any of us to hide.

Following fertility clinic malfunctions in Cleveland and San Francisco, many patients who have or had cancer are facing devastating losses, leaving many questions in the wake of these events.

Findings from an early phase clinical trial that used a so-called “smart bomb” virus — which was altered to attack tumor cells rather than normal cells — appeared to show promise in this area.

Researchers from Texas A&M University found that circadian rhythms may be key in the timing of when chemotherapy is administered to patients with glioblastoma.

After being diagnosed with glioblastoma, experimental immunotherapy saved his life.

It's hard to stop comparing our sick bodies to the people around us, but once we do, as both patients and caretakers, we learn to honor our own experiences and value ourselves in new and beautiful ways.

In recent years, major advances have been made in the immunotherapy scape, as it has become instrumental in revolutionizing the way oncologists treat a variety of cancers. However, its success in patients with brain cancer has been extremely limited.